Publicaciones en colaboración con investigadores/as de Hospital de Fuenlabrada (8)

2022

  1. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9

2021

  1. Parathormone levels add prognostic ability to N-terminal pro-brain natriuretic peptide in stable coronary patients

    ESC Heart Failure, Vol. 8, Núm. 4, pp. 2713-2722

2017

  1. Sun exposure influences the prognostic power of components of mineral metabolism in patients with coronary artery disease

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 27, Núm. 9, pp. 762-767

2016

  1. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease

    Diabetes/Metabolism Research and Reviews, Vol. 32, Núm. 7, pp. 685-693

  2. Design and rationale of a multicentre, randomised, double-blind, placebo-controlled clinical trial to evaluate the effect of Vitamin D on ventricular remodelling in patients with anterior myocardial infarction: The VITamin D in Acute Myocardial Infarction (VITDAMI) trial

    BMJ Open, Vol. 6, Núm. 8

  3. Important abnormalities of bone mineral metabolism are present in patients with coronary artery disease with a mild decrease of the estimated glomerular filtration rate

    Journal of Bone and Mineral Metabolism, Vol. 34, Núm. 5, pp. 587-598

2014

  1. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease

    PLoS ONE, Vol. 9, Núm. 4

2008

  1. Documento de consenso SEN-semFYC sobre la enfermedad renal crónica

    Nefrologia, Vol. 28, Núm. 3, pp. 273-282